SoftBank Group reported an 18% drop in fiscal first quarter profit as higher costs offset investment gains, though the company received a significant boost from Intel's tripled share price during the quarter. The results highlight mixed performance in the technology investor's AI-focused portfolio.
The S&P 500 and Dow Jones Industrial Average reached all-time highs on August 4-5, 2026, driven by optimism over potential progress on reopening the Strait of Hormuz and strong corporate earnings. The Nasdaq lagged as SpaceX and AMD shares fell despite positive earnings reports.
Uber Technologies shares dropped sharply after the company issued third-quarter earnings guidance below analyst expectations while announcing plans to invest over $10 billion in robotaxi expansion. The weak outlook comes amid uncertainty over its partnership with Waymo, though Uber maintains the Alphabet unit remains an important partner.
CVS Health exceeded second-quarter earnings and revenue estimates and raised its full-year guidance, driven by better-than-expected medical costs in its Aetna insurance business. The results signal improvement in the struggling insurance division.
Taiwanese electronics manufacturer Foxconn (Hon Hai Precision Industry Co.) posted record consolidated revenue exceeding NT$900 billion ($29.3 billion) in July 2026, marking a 54% year-over-year increase attributed to surging demand for artificial intelligence products.
SoftBank Group reported an 18% drop in fiscal first quarter profit as higher costs offset investment gains, though the company received a significant boost from Intel's tripled share price during the quarter. The results highlight mixed performance in the technology investor's AI-focused portfolio.
Merck beat second-quarter estimates and boosted its 2026 sales forecast after strong demand for newer drugs like Winrevair helped drive revenues higher, though the company cut profit guidance due to deal-related charges.
Palantir Technologies reported second-quarter sales far exceeding Wall Street estimates and raised its full-year revenue and income forecasts, with US commercial revenue more than doubling year-over-year. The stock surged 12% following the announcement.
Advanced Micro Devices reported second-quarter revenue of $11.54 billion, up 50% year-over-year and beating Wall Street estimates, with data center sales more than doubling. Despite projecting Q3 revenue of $13 billion above analyst expectations, the stock declined in extended trading as the strong results failed to exceed sky-high investor expectations.
Amazon reported AWS revenue accelerated for a fifth straight quarter, with cloud computing growth easing investor concerns about AI infrastructure returns. The strong results sent shares up 12% and demonstrated clear demand for Amazon's custom AI chips.
Amnon Shashua, who founded Mobileye in 1999 and has served as CEO since, announced he will step down as the autonomous-driving technology company pushes into robotaxi services and robotics. The leadership transition, combined with disappointing third-quarter guidance, sent shares down about 15% despite strong Q2 results.
Dutch chip equipment maker ASML announced it will grant all employees a one-time €20,000 restricted stock award vesting in 2030, contingent on continued employment. The bonus follows the company raising its full-year sales outlook to €43-45 billion as AI demand drives record chip equipment orders.
Taiwan Semiconductor Manufacturing Co. reported second-quarter revenue of $39.63 billion, a 36% year-over-year increase that exceeded market expectations and signals continued strong demand for AI hardware.
Block Inc. reported second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year profit outlook, driven by strong performance in Cash App and Square businesses. However, Bitcoin ecosystem gross profit fell 31% following Cash App fee cuts, leading to mixed stock market reaction.
Block (formerly Square) posted a $308.7 million net loss for Q1 2026 but beat Wall Street's adjusted profit expectations and raised its full-year gross profit forecast, sending shares up nearly 8% after hours.
Novo Nordisk's stock price and earnings received a boost following less-negative news about the development of an oral version of its blockbuster weight loss drug Wegovy, marking progress in the company's efforts to create a pill formulation.
